JP2018507260A - 鉄欠乏性貧血の治療におけるクエン酸第二鉄の使用 - Google Patents

鉄欠乏性貧血の治療におけるクエン酸第二鉄の使用 Download PDF

Info

Publication number
JP2018507260A
JP2018507260A JP2017564757A JP2017564757A JP2018507260A JP 2018507260 A JP2018507260 A JP 2018507260A JP 2017564757 A JP2017564757 A JP 2017564757A JP 2017564757 A JP2017564757 A JP 2017564757A JP 2018507260 A JP2018507260 A JP 2018507260A
Authority
JP
Japan
Prior art keywords
ferric citrate
iron
months
subject
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017564757A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018507260A5 (enExample
Inventor
ポラドス エンリクエ
ポラドス エンリクエ
デービッド シェメシュ シャイ
デービッド シェメシュ シャイ
ベントスル ロン
ベントスル ロン
Original Assignee
ケリク バイオファーマシューティカルス， インコーポレーテッド
ケリク バイオファーマシューティカルス， インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ケリク バイオファーマシューティカルス， インコーポレーテッド, ケリク バイオファーマシューティカルス， インコーポレーテッド filed Critical ケリク バイオファーマシューティカルス， インコーポレーテッド
Publication of JP2018507260A publication Critical patent/JP2018507260A/ja
Publication of JP2018507260A5 publication Critical patent/JP2018507260A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP2017564757A 2015-03-04 2016-03-03 鉄欠乏性貧血の治療におけるクエン酸第二鉄の使用 Pending JP2018507260A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562127963P 2015-03-04 2015-03-04
US62/127,963 2015-03-04
PCT/US2016/020575 WO2016141124A1 (en) 2015-03-04 2016-03-03 Use of ferric citrate in the treatment of iron-deficiency anemia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021010151A Division JP2021091686A (ja) 2015-03-04 2021-01-26 鉄欠乏性貧血の治療におけるクエン酸第二鉄の使用

Publications (2)

Publication Number Publication Date
JP2018507260A true JP2018507260A (ja) 2018-03-15
JP2018507260A5 JP2018507260A5 (enExample) 2019-04-11

Family

ID=56848619

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017564757A Pending JP2018507260A (ja) 2015-03-04 2016-03-03 鉄欠乏性貧血の治療におけるクエン酸第二鉄の使用
JP2021010151A Pending JP2021091686A (ja) 2015-03-04 2021-01-26 鉄欠乏性貧血の治療におけるクエン酸第二鉄の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021010151A Pending JP2021091686A (ja) 2015-03-04 2021-01-26 鉄欠乏性貧血の治療におけるクエン酸第二鉄の使用

Country Status (15)

Country Link
US (2) US20180071243A1 (enExample)
EP (1) EP3265077A4 (enExample)
JP (2) JP2018507260A (enExample)
KR (1) KR20170123664A (enExample)
CN (1) CN107530310A (enExample)
AU (1) AU2016226250B2 (enExample)
BR (1) BR112017018963A2 (enExample)
CA (1) CA2978073A1 (enExample)
EA (1) EA201791960A1 (enExample)
HK (2) HK1246649A1 (enExample)
IL (1) IL254125A0 (enExample)
MX (1) MX2017011169A (enExample)
SG (1) SG11201707120PA (enExample)
TW (2) TW202302083A (enExample)
WO (1) WO2016141124A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102573807A (zh) 2009-07-21 2012-07-11 凯克斯生物制药公司 柠檬酸铁剂型
JP7387435B2 (ja) * 2017-09-19 2023-11-28 日本たばこ産業株式会社 過多月経患者及び／又は過多月経を伴う婦人科疾患を有する患者における鉄欠乏性貧血の予防及び／又は治療におけるクエン酸第二鉄の使用
FR3075601A1 (fr) * 2017-12-21 2019-06-28 Clarisse Le Court Complements alimentaires et leur utilisation sur les menstruations
WO2020247935A1 (en) * 2019-06-07 2020-12-10 Arizona Board Of Regents On Behalf Of Arizona State University Body fluid iron level panel analyzer
WO2022251563A1 (en) 2021-05-27 2022-12-01 Keryx Biopharmaceuticals, Inc. Pediatric formulations of ferric citrate
WO2023047424A1 (en) * 2022-04-29 2023-03-30 West Bengal Chemical Industries Limited Pharmaceutical acceptable iron (iii) coordination complex having high phosphate binding capacity and preparation thereof
KR102623739B1 (ko) * 2022-07-28 2024-01-11 주식회사 페라메드 시트르산과 철을 포함하는 착화합물 및 그를 포함하는 식품 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005225874A (ja) * 2004-01-14 2005-08-25 Gekkeikan Sake Co Ltd 鉄補給剤及びその利用
WO2013192565A2 (en) * 2012-06-21 2013-12-27 Keryx Biopharmaceuticals, Inc. Use of ferric citrate in the treatment of chronic kidney disease patients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8093423B2 (en) * 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
TWI335218B (en) * 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
WO2005067970A1 (ja) * 2004-01-14 2005-07-28 Gekkeikan Sake Co., Ltd. 鉄補給剤及びその利用
JP5667343B2 (ja) * 2005-08-18 2015-02-12 パニオン アンド ビーエフ バイオテック インコーポレーテッド 医薬グレードの第二鉄有機化合物、その使用およびその製造方法
US20120288531A1 (en) * 2011-01-14 2012-11-15 Shmuel Tuvia pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005225874A (ja) * 2004-01-14 2005-08-25 Gekkeikan Sake Co Ltd 鉄補給剤及びその利用
WO2013192565A2 (en) * 2012-06-21 2013-12-27 Keryx Biopharmaceuticals, Inc. Use of ferric citrate in the treatment of chronic kidney disease patients

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
日本内科学会雑誌, vol. 79, no. 3, JPN7019004235, 1990, pages 142 - 145, ISSN: 0004187930 *

Also Published As

Publication number Publication date
IL254125A0 (en) 2017-10-31
CN107530310A (zh) 2018-01-02
KR20170123664A (ko) 2017-11-08
US20240075006A1 (en) 2024-03-07
HK1246649A1 (zh) 2018-09-14
US20180071243A1 (en) 2018-03-15
AU2016226250A1 (en) 2017-09-28
TWI812580B (zh) 2023-08-21
WO2016141124A1 (en) 2016-09-09
SG11201707120PA (en) 2017-09-28
MX2017011169A (es) 2017-11-09
AU2016226250B2 (en) 2021-05-27
EA201791960A1 (ru) 2018-01-31
TW202302083A (zh) 2023-01-16
EP3265077A1 (en) 2018-01-10
BR112017018963A2 (pt) 2018-05-15
EP3265077A4 (en) 2018-10-24
TW201639558A (zh) 2016-11-16
HK1248589A1 (zh) 2018-10-19
CA2978073A1 (en) 2016-09-09
JP2021091686A (ja) 2021-06-17

Similar Documents

Publication Publication Date Title
JP2021091686A (ja) 鉄欠乏性貧血の治療におけるクエン酸第二鉄の使用
AU2018203205B2 (en) Use of ferric citrate in the treatment of chronic kidney disease patients
JP6828100B2 (ja) 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄
US10716802B2 (en) Compounds to modulate intestinal absorption of nutrients
KR20040047771A (ko) 신규의 치환 벤즈이미다졸 제형 및 그 사용방법
KR20040099265A (ko) 신규의 치환 벤즈이미다졸 제형 및 그 사용방법
JP6792269B2 (ja) 夜間胃酸過分泌に対するベンズイミダゾール誘導体の使用
JP2025122089A (ja) ベンズイミダゾール誘導体化合物を含む医薬組成物
JP2025148497A (ja) 過多月経患者及び／又は過多月経を伴う婦人科疾患を有する患者における鉄欠乏性貧血の予防及び／又は治療におけるクエン酸第二鉄の使用
JP2008534521A (ja) ピリドキサール５’−リン酸の静脈用製剤、調製方法、およびその使用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190301

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190301

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200107

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20191226

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200306

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200706

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200929

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20210126

C116 Written invitation by the chief administrative judge to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C116

Effective date: 20210209

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20210209

C27A Decision to dismiss

Free format text: JAPANESE INTERMEDIATE CODE: C2711

Effective date: 20210330

C032 Notice prior to dismissal

Free format text: JAPANESE INTERMEDIATE CODE: C032

Effective date: 20210427

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20210427